drugset / Trial / NCT06987643
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this interventional study is to determine whether neflamapimod can improve residual physical disability and/or cognitive dysfunction after Moderate to Severe Acute Ischaemic Stroke.
Timeline
- Start
- 2025-06-20
- Primary completion
- 2026-09-30
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neflamapimod | Small molecule | 40 mg | Oral |
| Comparator | Neflamapimod | Small molecule | 80 mg | Oral |